it’s quite simple, but does seem very confusing for you. Hope we don’t have to keep going round in ridiculous circles for weeks.
so for the last time:
1) you are wrong. HCT do not have distribution rights for some parts of the world. They now have global distribution rights. The reason for this if you bother to research it deeply enough is the pathaway product was jointly developed by Dr Arthur Martin (GICC and HCT scientific advisory board member), and DrRajen (CEO HCT)
2) the only COVID killing active ingredient in Invisisheild is pathaway. Whether it’s ‘just one 2%’ ingredient or otherwise whether or not your product kills COVID is the only thing anyone cares about right now.
3) there is zero information anywhere that (seperate to pathaway), there is any COVID killing ‘microbiological’ action from SKN products. In fact it’s a plain silly illogical statement given they have decided to buy from HCT
I don’t actually think your dumb, so let’s just cut the deliberate diversion posting. I hope SKN make it billions as you you will paying a decent portion of it to HCT.
But pretending you have something ‘seperate’ or ‘different’ to pathaway is in terms of COVID killing is getting boring for everyone. If SKN did they wouldn’t have signed up to give HCT a constant ongoing revenue stream from their products.
SKN Price at posting:
10.5¢ Sentiment: Hold Disclosure: Not Held
